High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Hepcidin in iron overload disorders
Papanikolaou, G., Tzilianos, M., Christakis, J. I., Bogdanos, D., Tsimirika, K., MacFarlane, J., Goldberg, Y. P., Sakellaropoulos, N., Ganz, T., & Nemeth, E. (2005) · Blood · doi:10.1182/blood-2004-12-4844 · Cited by 445 · cited 1×
“However, it was recently shown that hepcidin levels are decreased in individuals with β-thalassemia syndrome”
BackgroundSelf-citationHepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages
GANZ, T. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2004.08.020 · Cited by 393 · cited 1×
“Hepcidin is a small peptide produced in the liver that reduces iron absorption by causing the degradation of the enterocyte iron transporter ferroporti”
BackgroundSelf-citationTruksa, J., Peng, H., Lee, P., & Beutler, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603124103 · Cited by 309 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundHsiao, E. C., Koniaris, L. G., Zimmers-Koniaris, T., Sebald, S. M., Huynh, T. V., & Lee, S.-J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.10.3742-3751.2000 · Cited by 302
PLAB, a novel placental bone morphogenetic protein
Hromas, R., Hufford, M., Sutton, J., Xu, D., Li, Y., & Lu, L. (1997) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(97)00122-x · Cited by 231 · cited 1×
“The high amount of GDF15 expressed during pregnancy has been attributed to placental expressio”
BackgroundKoopmann, J., Rosenzweig, C. N. W., Zhang, Z., Canto, M. I., Brown, D. A., Hunter, M., Yeo, C., Chan, D. W., Breit, S. N., & Goggins, M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0564 · Cited by 213
Kattamis, A., Papassotiriou, I., Palaiologou, D., Apostolakou, F., Galani, A., Ladis, V., Sakellaropoulos, N., & Papanikolaou, G. (2006) · PubMed · Cited by 174
Urinary hepcidin in congenital chronic anemias
Kearney, S. L., Nemeth, E., Neufeld, E. J., Thapa, D., Ganz, T., Weinstein, D. A., & Cunningham, M. J. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20616 · Cited by 172 · cited 1×
“3 ) is consistent with the reduction in urinary hepcidin detected in vivo in patients with thalassemia majo”
ResultSelf-citationMacrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation.
Yang, H. S., Filipovic, Z., Brown, D. A., Breit, S. N., & Vassilev, L. T. (2003) · PubMed · Cited by 168
Pootrakul, P., Sirankapracha, P., Hemsorach, S., Moungsub, W., Kumbunlue, R., Piangitjagum, A., Wasi, P., Ma, L., & Schrier, S. L. (2000) · Blood · doi:10.1182/blood.v96.7.2606 · Cited by 167
NSAID Activated Gene (NAG-1), a Modulator of Tumorigenesis
Eling, T. E., Baek, S.-J., Shim, M.-S., & Lee, C.-H. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.6.649 · Cited by 123
Self-citationMarjono, A. B., Brown, D. A., Horton, K. E., Wallace, E. M., Breit, S. N., & Manuelpillai, U. (2002) · Placenta · doi:10.1053/plac.2002.0881 · Cited by 99 · cited 1×
“Such high levels are also measured during pregnancy, when there is a progressive rise in maternal GDF15 concentration from a normal level to >30,000 pg/ml in the third trimeste”
BackgroundThe Ins and Outs of Iron Homeostasis
Donovan, A., Roy, C. N., & Andrews, N. C. (2006) · Physiology · doi:10.1152/physiol.00052.2005 · Cited by 98 · cited 1×
“dtd" [ ]> Because humans have no physiological means for excreting iron, hepcidin-regulated intestinal absorption represents a principal mechanism for iron homeostasis in human”
BackgroundMillard, K. N., Frazer, D. M., Wilkins, S. J., & Anderson, G. J. (2004) · Gut · doi:10.1136/gut.2003.031153 · Cited by 93 · cited 1×
“There is increased iron absorption during pregnancy, and consistent with the results reported here, pregnancy is also associated with suppression of hepcidin expression in animal model”
ResultWojda, U., Noel, P., & Miller, J. L. (2002) · Blood · doi:10.1182/blood.v99.8.3005 · Cited by 88
Self-citationRegulation of bone morphogenetic proteins in early embryonic development
Yamamoto, Y., & Oelgeschl�ger, M. (2004) · Die Naturwissenschaften · doi:10.1007/s00114-004-0575-z · Cited by 83 · cited 1×
“TWSG1 can function as a BMP agonist or antagonist in skeletal and craniofacial development in mic”
BackgroundWeizer‐Stern, O., Adamsky, K., Amariglio, N., Levin, C., Koren, A., Breuer, W., Rachmilewitz, E., Breda, L., Rivella, S., Ioav Cabantchik, Z., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06258.x · Cited by 80 · cited 1×
“Moreover, serum from individuals with β-thalassemia inhibits hepcidin mRNA expression in hepatoma cell”
BackgroundUpregulation of hepcidin by interleukin-1β in human hepatoma cell lines
Inamura, J., Ikuta, K., Jimbo, J., SHINDO, M., SATO, K., Torimoto, Y., & KOHGO, Y. (2005) · Hepatology Research · doi:10.1016/j.hepres.2005.08.005 · Cited by 46
Iron stores in adults with sickle cell anemia.
Rao, K. R. P., Patel, A. R., McGinnis, P., & Patel, M. (1984) · PubMed · Cited by 27
Restrictive lung disease and serum TGF-beta1 in thalassemia major children.
Sritippayawan, S., Lekhanont, P., Harnruthakorn, C., Samransamruajkit, R., Deerojanawong, J., Seksarn, P., Poovorawan, Y., & Prapphal, N. (2005) · PubMed · Cited by 8
THALASSEMIA AS A PROLIFERATIVE DISORDER
Nathan, D. G. (1964) · Medicine · doi:10.1097/00005792-196411000-00021 · Cited by 3 · cited 1×
“Hepcidin assays with recombinant proteins were performed under the conditions describe”
Method
Cited by
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282
Self-citationWeiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
Self-citation
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.